Analysts who follow Evelo Biosciences Inc (EVLO) on average expect it to climb 327.40% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns Evelo Biosciences Inc an Analyst Ranking of 63, which means it ranks higher than 63 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating EVLO a Strong Buy today. Find out what this means to you and get the rest of the rankings on EVLO!